The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
The Impact of MicroRNA-223-3p on IL-17 Receptor D Expression in Synovial Cells
Abstract
OBJECTIVE: Rheumatoid arthritis (RA) is an autoimmune inflammatory disease affecting joints. Elevated plasma levels of microRNA-223-3p (miR-223-3p) in patients with RA are implicated in the pathogenesis of the disease. This study aimed to analyze the functional role of miR-223-3p in the pathogenesis of RA by overexpressing miR-223-3p in synovial cell lines. METHODS: Arthritis was induced in the RA model of SKG mice by injection of ß-glucan. The histopathologic features of joints were examined using hematoxylin and eosin and immunohistochemical staining. Plasma levels of miRNA were determined by panel real-time PCR analysis. Target genes of the differentially expressed miRNAs in SKG mice were analyzed using miRNA target prediction algorithms. The dual-luciferase reporter system was used to evaluate the relationship between miR-223-3p and IL-17 receptor D (IL-17RD). The activity of miR-223-3p was analyzed by transfection of plasmid vectors overexpressing miR-223-3p into IL-17RD-expressing NIH3T3 and MH7A cell lines. Il6 and Il17rd mRNA expression was analyzed by quantitative real-time PCR. IL-17RD protein expression was analyzed by western blot analysis. RESULTS: We identified 17 upregulated miRNAs (fold change > 2.0) in plasma of SKG mice injected with ß-glucan relative to untreated SKG mice. Il17rd was identified as the candidate target gene of miR-223-3p using five miRNA target prediction algorithms. The transfection of plasmid vectors overexpressing miR-223-3p into NIH3T3 and MH7A cells resulted in the downregulation of Il17rd expression and upregulation of Il6 expression. Expression of miR-223-3p and Il6 mRNA in MH7A cells was upregulated; however, that of Il17rd mRNA was downregulated following TNF-α stimulation. IL-17RD expression in synovial tissues from SKG mice and RA patients was inversely correlated with the severity of arthritis. CONCLUSION: This study is the first to demonstrate that miR-223-3p downregulates IL-17RD in both mouse and human cells; miR-223-3p may contribute to the pathogenesis of RA by downregulating the expression of IL-17RD and upregulating that of IL-6 in synovial cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Overexpression of miR-223-3p could down-regulate IL-17RD expression and alleviate RA-induced injury 100, 101.”
From miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation (2021) · cites this paper as [100]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nakamachi, Y., Kawano, S., Takenokuchi, M., Nishimura, K., Sakai, Y., Chin, T., Saura, R., Kurosaka, M., & Kumagai, S. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24475 · Cited by 332
Identification of Sef, a novel modulator of FGF signalling
Tsang, M., Friesel, R., Kudoh, T., & Dawid, I. B. (2002) · Nature Cell Biology · doi:10.1038/ncb749 · Cited by 304
Structural basis of receptor sharing by interleukin 17 cytokines
Ely, L. K., Fischer, S., & Garcia, K. C. (2009) · Nature Immunology · doi:10.1038/ni.1813 · Cited by 195
Research works printed but not linked: 46
- DP Bartel, 2009, MicroRNAs: target recognition and regulatory functions, Cell, 136, 215, 10.1016/j.cell.2009.01.002 · DOI · Paper page
- W Filipowicz, 2008, Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?, Nat Rev Genet, 9, 102, 10.1038/nrg2290 · DOI
- J Krol, 2010, The widespread regulation of microRNA biogenesis, function and decay, Nat Rev Genet, 11, 597, 10.1038/nrg2843 · DOI · Paper page
- H Guo, 2010, Mammalian microRNAs predominantly act to decrease target mRNA levels, Nature, 466, 835, 10.1038/nature09267 · DOI · Paper page
- D Sayed, 2011, MicroRNAs in development and disease, Physiol Rev, 91, 827, 10.1152/physrev.00006.2010 · DOI · Paper page
- G Reid, 2011, Circulating microRNAs: association with disease and potential use as biomarkers, Crit Rev Oncol Hematol, 80, 193, 10.1016/j.critrevonc.2010.11.004 · DOI · Paper page
- IB McInnes, 2011, The pathogenesis of rheumatoid arthritis, N Engl J Med, 365, 2205, 10.1056/NEJMra1004965 · DOI · Paper page
- T Nakasa, 2008, Expression of microRNA-146 in rheumatoid arthritis synovial tissue, Arthritis Rheum, 58, 1284, 10.1002/art.23429 · DOI · Paper page
- J Stanczyk, 2008, Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis, Arthritis Rheum, 58, 1001, 10.1002/art.23386 · DOI · Paper page
- G Alsaleh, 2009, Bruton’s tyrosine kinase is involved in miR-346-related regulation of IL-18 release by lipopolysaccharide-activated rheumatoid fibroblast-like synoviocytes, J Immunol, 182, 5088, 10.4049/jimmunol.0801613 · DOI
- V Fulci, 2010, miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis, Hum Immunol, 71, 206, 10.1016/j.humimm.2009.11.008 · DOI · Paper page
- J Stanczyk, 2011, Altered expression of miR-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation, Arthritis Rheum, 63, 373, 10.1002/art.30115 · DOI · Paper page
- I Alevizos, 2010, MicroRNAs as biomarkers in rheumatic diseases, Nat Rev Rheumatol, 6, 391, 10.1038/nrrheum.2010.81 · DOI · Paper page
- T Niimoto, 2010, MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients, BMC Musculoskelet Disord, 11, 209, 10.1186/1471-2474-11-209 · DOI · Paper page
- CZ Chen, 2004, MicroRNAs modulate hematopoietic lineage differentiation, Science, 303, 83, 10.1126/science.1091903 · DOI · Paper page
- SH Ramkissoon, 2006, Hematopoietic-specific microRNA expression in human cells, Leuk Res, 30, 643, 10.1016/j.leukres.2005.09.001 · DOI · Paper page
- F Fazi, 2005, A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBP-alpha regulates human granulopoiesis, Cell, 123, 819, 10.1016/j.cell.2005.09.023 · DOI · Paper page
- H Shibuya, 2012, Overexpression of microRNA-223 in rheumatoid arthritis synovium controls osteoclast differentiation, Mod Rheumatol, 23, 674, 10.3109/s10165-012-0710-1 · doi:10.3109/s10165-012-0710-1
- K Murata, 2010, Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis, Arthritis Res Ther, 12, R86, 10.1186/ar3013 · DOI · Paper page
- T Sugatani, 2009, Impaired micro-RNA pathways diminish osteoclast differentiation and function, J Biol Chem, 284, 4667, 10.1074/jbc.M805777200 · DOI · Paper page
- T Korn, 2009, IL-17 and Th17 cells, Annu Rev Immunol, 27, 485, 10.1146/annurev.immunol.021908.132710 · DOI · Paper page
- Z. Rong, 2009, IL-17RD (Sef or IL-17RLM) interacts with IL-17 receptor and mediates IL-17 signaling, Cell Res, 19, 208, 10.1038/cr.2008.320 · DOI
- N Sakaguchi, 2003, Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice, Nature, 426, 454, 10.1038/nature02119 · DOI · Paper page
- S Tsunemi, 2010, Effects of the novel immunosuppressant FTY720 in a murine rheumatoid arthritis model, Clin Immunol, 136, 197, 10.1016/j.clim.2010.03.428 · DOI
- S Tsunemi, 2013, Molecular targeting of hepatocyte growth factor by an antagonist, NK4, in the treatment of rheumatoid arthritis, Arthritis Res Ther, 15, R75, 10.1186/ar4252 · DOI
- N Moriya, 2012, Effect of lipopolysaccharide on the xenobiotic-induced expression and activity of hepatic cytochrome P450 in mice, Biol Pharm Bull, 35, 473, 10.1248/bpb.35.473 · DOI
- H Zheng, 2013, Advances in the techniques for the prediction of microRNA targets, Int J Mol Sci, 14, 8179, 10.3390/ijms14048179 · DOI
- Y Yan, 2007, Irradiation-induced G2/M checkpoint response requires ERK1/2 activation, Oncogene, 26, 4689, 10.1038/sj.onc.1210268 · DOI
- K Miyazawa, 1988, Establishment and characterization of novel human rheumatoid fibroblast-like synoviocyte line, MH7A, immortalized with SV40T antigen, J Biochem, 124, 1153, 10.1093/oxfordjournals.jbchem.a022233 · doi:10.1093/oxfordjournals.jbchem.a022233
- M Tesmer, 2008, Th17 cells in human disease, Immunol Rev, 223, 87, 10.1111/j.1600-065X.2008.00628.x · DOI · Paper page
- N Li, 2013, Pathologic finding of increased expression of interleukin-17 in the synovial tissue of rheumatoid arthritis patients, Int J Clin Exp Pathol, 6, 1375
- Y Iwakura, 2008, The roles of IL-17A in inflammatory immune responses and host defense against pathogens, Immunol Rev, 226, 57, 10.1111/j.1600-065X.2008.00699.x · DOI · Paper page
- G Azizi, 2013, Th17 cells in immunopathogenesis and treatment of rheumatoid arthritis, Int J Rheum Dis, 16, 243, 10.1111/1756-185X.12132 · DOI
- ME Truchetet, 2013, IL -17 in the rheumatologist’s line of sight, Biomed Res Int, 2013, 295132, 10.1155/2013/295132 · DOI
- TA Moseley, 2003, Interleukin-17 family and IL-17 receptors, Cytokine Growth Factor Rev, 14, 155, 10.1016/S1359-6101(03)00002-9 · DOI · Paper page
- M Furthauer, 2002, Sef is a feedback induced antagonist of Ras/MAPK-mediated FGF signalling, Nat Cell Biol, 4, 170, 10.1038/ncb750 · DOI · Paper page
- D Kovalenko, 2003, Sef inhibits fibroblast growth factor signaling by inhibiting FGFR1 tyrosine phosphorylation and subsequent ERK activation, J Biol Chem, 278, 14087, 10.1074/jbc.C200606200 · DOI
- E Preger, 2004, Alternative splicing generates an isoform of the human Sef gene with altered subcellular localization and specificity, Proc Natl Acad Sci USA, 101, 1229, 10.1073/pnas.0307952100 · DOI
- S Torii, 2004, Sef is a spatial regulator for Ras/MAP kinase signaling, Dev Cell, 7, 33, 10.1016/j.devcel.2004.05.019 · DOI · Paper page
- S Xiong, 2003, hSef inhibits PC-12 cell differentiation by interfering with Ras-mitogen-activated protein kinase MAPK signaling, J Biol Chem, 278, 50273, 10.1074/jbc.M306936200 · DOI
- RB Yang, 2003, A novel interleukin-17 receptor-like protein identified in human umbilical vein endothelial cells antagonizes basic fibroblast growth factor-induced signaling, J Biol Chem, 278, 33232, 10.1074/jbc.M305022200 · DOI
- I Ziv, 2006, The human sef-a isoform utilizes different mechanisms to regulate receptor tyrosine kinase signaling pathways and subsequent cell fate, J Biol Chem, 281, 39225, 10.1074/jbc.M607327200 · DOI
- M Mellett, 2015, Orphan receptor IL-17RD regulates Toll-like receptor signalling via SEFIR/TIR interactions, Nat Commun, 6, 6669, 10.1038/ncomms7669 · DOI
- Y Fuchs, 2012, Sef is a inhibitor of proinflammatory cytokine signaling, acting by cytoplasmic sequestration of NF-kappaB, Dev Cell, 23, 611, 10.1016/j.devcel.2012.07.013 · DOI
- YT Li, 2012, Amelioration of collagen-induced arthritis in mice by lentivirus-mediated silencing of microRNA-223, Arthritis Rheum, 64, 3240, 10.1002/art.34550 · DOI
- M Filková, 2014, Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis, Ann Rheum Dis, 73, 1898, 10.1136/annrheumdis-2012-202815 · DOI · Paper page
Cited by
miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation
Jiao, P., Wang, X.-P., Luoreng, Z.-M., Yang, J., Jia, L., Ma, Y., & Wei, D.-W. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59876 · Cited by 151
TMIGD1: Emerging functions of a tumor supressor and adhesion receptor
Thüring, E.-M., Hartmann, C., Schwietzer, Y. A., & Ebnet, K. (2023) · Oncogene · doi:10.1038/s41388-023-02696-5 · Cited by 11
Metadata
- Authors
- Moriya, N., Shibasaki, S., Karasaki, M., & Iwasaki, T.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-01-05
- Volume
- 12
- Issue
- 1
- Pages
- e0169702
- ISSN
- 1932-6203
- Cited by
- 23
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Impact of MicroRNA-223-3p on IL-17 Receptor D Expression in Synovial Cells. https://app.cochat.ai/papers/10.1371/journal.pone.0169702
- The paper
- Moriya, N., Shibasaki, S., Karasaki, M., & Iwasaki, T. (2017). The Impact of MicroRNA-223-3p on IL-17 Receptor D Expression in Synovial Cells. PLOS ONE. https://doi.org/10.1371/journal.pone.0169702
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.